Evaluation of Seasonal Inactivated Influenza Vaccines Prophylactic Efficacy
Relevance. Seasonal flu vaccination is still the most effective way to protect against flu viruses and help to reduce the burden of flu illnesses. Another possible benefit is the impact of yearly vaccines on severity of breakthrough infection. In this regard, the issue of choosing safe vaccine with...
| Published in: | Эпидемиология и вакцинопрофилактика |
|---|---|
| Main Authors: | K. V. Zhdanov, K. Kasyanenko, O. V. Mal'cev, N. I. L'vov, D. A. Lioznov, I. I. Lapikov, K. S. Ivanov |
| Format: | Article |
| Language: | Russian |
| Published: |
Numikom LLC
2022-11-01
|
| Subjects: | |
| Online Access: | https://www.epidemvac.ru/jour/article/view/1679 |
Similar Items
Results of Clinical Trials of the First Russian 4-valent Flu Vaccine
by: D. A. Lioznov
Published: (2018-09-01)
by: D. A. Lioznov
Published: (2018-09-01)
Knowledge, attitudes, beliefs, and barriers associated with the uptake of influenza vaccine among pregnant women
by: Ahmed Y. Mayet, et al.
Published: (2017-01-01)
by: Ahmed Y. Mayet, et al.
Published: (2017-01-01)
Reply letter to “Vaccine effectiveness of recombinant and standard dose influenza vaccines against outpatient illness during 2018–2019 and 2019–2020 calculated using a retrospective test-negative design”
by: Sanjay Hadigal, et al.
Published: (2023-08-01)
by: Sanjay Hadigal, et al.
Published: (2023-08-01)
Reply letter to “Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized Phase III trial”
by: Sanjay Hadigal, et al.
Published: (2022-11-01)
by: Sanjay Hadigal, et al.
Published: (2022-11-01)
Trends in influenza vaccine disparities in the U.S. following the introduction of COVID-19: Insights from the national health interview survey
by: Margaret L. Lind, et al.
Published: (2025-12-01)
by: Margaret L. Lind, et al.
Published: (2025-12-01)
A 12-month follow-up of an influenza vaccination campaign based on voluntary adherence: report on upper-respiratory symptoms among volunteers and non-volunteers
by: Páris Ali Ramadan, et al.
by: Páris Ali Ramadan, et al.
Public knowledge on influenza and influenza vaccines
by: Adrianna Gorecka, et al.
Published: (2021-08-01)
by: Adrianna Gorecka, et al.
Published: (2021-08-01)
Do We Still Need to Vaccinate Patients Against Flu After the Flu Infection?
by: Dilan Yağmur KUTLAY, et al.
Published: (2024-08-01)
by: Dilan Yağmur KUTLAY, et al.
Published: (2024-08-01)
Immunogenicity and safety of inactivated quadrivalent influenza vaccine compared with the trivalent vaccine for influenza infection: an overview of systematic reviews
by: Rodrigo Luiz Carregaro, et al.
Published: (2023-08-01)
by: Rodrigo Luiz Carregaro, et al.
Published: (2023-08-01)
Trivalent inactivated influenza vaccine response and immunogenicity assessment after one week and three months in repeatedly vaccinated adults
by: Ahmed Tawfik, et al.
Published: (2023-12-01)
by: Ahmed Tawfik, et al.
Published: (2023-12-01)
Safety of anti-influenza vaccination during pregnancy
by: Marta Kozłowska, et al.
Published: (2020-09-01)
by: Marta Kozłowska, et al.
Published: (2020-09-01)
Quadrivalent Live-Attenuated Influenza Vaccine in Milan preschools: an Italian experience of school-located flu vaccination within the 2022–2023 season
by: Stefania Roncaglia, et al.
Published: (2024-05-01)
by: Stefania Roncaglia, et al.
Published: (2024-05-01)
Next-generation intranasal influenza vaccines: mechanisms, platforms, and translational progress
by: Laise Rodrigues Reis, et al.
Published: (2026-04-01)
by: Laise Rodrigues Reis, et al.
Published: (2026-04-01)
Epidemiology of influenza over a ten-year period in Belgium: overview of the historical and current evidence
by: A. Prezzi, et al.
Published: (2023-11-01)
by: A. Prezzi, et al.
Published: (2023-11-01)
Nurses’ Influenza Vaccination and Hesitancy: A Systematic Review of Qualitative Literature
by: Natacha Pinatel, et al.
Published: (2022-06-01)
by: Natacha Pinatel, et al.
Published: (2022-06-01)
Evaluation of knowledge and barriers of influenza vaccine uptake among university students in Saudi Arabia; a cross-sectional analysis
by: Tauqeer Hussain Mallhi, et al.
Published: (2022-09-01)
by: Tauqeer Hussain Mallhi, et al.
Published: (2022-09-01)
Influenza Vaccine Uptake in Italy—The 2022–2023 Seasonal Influenza Vaccination Campaign in Italy: An Update from the OBVIOUS Project
by: Angelo Capodici, et al.
Published: (2024-03-01)
by: Angelo Capodici, et al.
Published: (2024-03-01)
The Knowledge and Perceptions of Florida Pharmacists in Administering Inactivated Influenza Vaccines to Pregnant Women
by: Oluyemisi Falope, et al.
Published: (2021-04-01)
by: Oluyemisi Falope, et al.
Published: (2021-04-01)
Impact of Influenza Vaccination on Mortality in the Oldest Old: A Propensity Score-Matched Cohort Study
by: Pauline Walzer, et al.
Published: (2020-07-01)
by: Pauline Walzer, et al.
Published: (2020-07-01)
Systematic Review of Safety of MF59-Adjuvanted Influenza Vaccine in Older Adults
by: Matias Edgardo Manzotti, et al.
Published: (2026-04-01)
by: Matias Edgardo Manzotti, et al.
Published: (2026-04-01)
Clinical and immunological efficacy of immunoprophylaxis of influenza in children with allergic diseases
by: E. G. Bokuchava, et al.
Published: (2016-12-01)
by: E. G. Bokuchava, et al.
Published: (2016-12-01)
NEW GENERATION DOMESTIC VACCINE FOR PROPHYLAXIS OF FLU
by: O. V. Shamsheva
Published: (2015-09-01)
by: O. V. Shamsheva
Published: (2015-09-01)
An Economic Evaluation of the Adjuvanted Quadrivalent Influenza Vaccine Compared with Standard-Dose Quadrivalent Influenza Vaccine in the Spanish Older Adult Population
by: Anna Fochesato, et al.
Published: (2022-08-01)
by: Anna Fochesato, et al.
Published: (2022-08-01)
Preventive vaccination against influenza today
by: O. S. Konshina, et al.
Published: (2016-12-01)
by: O. S. Konshina, et al.
Published: (2016-12-01)
Results of a clinical study of the influenza tetravalent inactivated subunit adjuvant vaccine Grippol Quadrivalent in children aged 6 months to 5 years (inclusive)
by: Viktor V. Romanenko, et al.
Published: (2024-07-01)
by: Viktor V. Romanenko, et al.
Published: (2024-07-01)
The Influence of COVID-19 on Influenza and Respiratory Syncytial Virus Activities
by: Pritish Mondal, et al.
Published: (2022-02-01)
by: Pritish Mondal, et al.
Published: (2022-02-01)
A Comparison of the Level of Acceptance and Hesitancy towards the Influenza Vaccine and the Forthcoming COVID-19 Vaccine in the Medical Community
by: Magdalena Grochowska, et al.
Published: (2021-05-01)
by: Magdalena Grochowska, et al.
Published: (2021-05-01)
Influenza Vaccination Assessment according to a Value-Based Health Care Approach
by: Giovanna Elisa Calabrò, et al.
Published: (2022-10-01)
by: Giovanna Elisa Calabrò, et al.
Published: (2022-10-01)
Seasonal Influenza Vaccination Uptake, Illness and Economic Burden, and Vaccine Information Exposure Among Young Adults in the San Francisco Bay Area
by: Taiwo Opeyemi Aremu, et al.
Published: (2026-06-01)
by: Taiwo Opeyemi Aremu, et al.
Published: (2026-06-01)
Efficacy, safety and immunogenicity of a trivalent inactivated split influenza vaccine in patients with rheumatic diseases
by: D. V. Bukhanova, et al.
Published: (2018-07-01)
by: D. V. Bukhanova, et al.
Published: (2018-07-01)
An Assessment of Pharmacy School Curricula in Florida and Inactivated Influenza Vaccine (IIV) Administration to Pregnant Women
by: Oluyemisi Falope, et al.
Published: (2021-03-01)
by: Oluyemisi Falope, et al.
Published: (2021-03-01)
Attitudes and Perception of Healthcare Workers Concerning Influenza Vaccination during the 2019/2020 Season: A Survey of Sicilian University Hospitals
by: Claudio Costantino, et al.
Published: (2020-11-01)
by: Claudio Costantino, et al.
Published: (2020-11-01)
INFLUENZA VACCINATION OF CHILDREN OF PRESCHOOL AGE IN THE RUSSIAN FEDERATION: COST-EFFECTIVENESS OF QUADRIVALENT VACCINE
by: A. V. Rudakova, et al.
Published: (2019-03-01)
by: A. V. Rudakova, et al.
Published: (2019-03-01)
Influenza vaccination in the elderly
by: Jan Smetana, et al.
Published: (2018-03-01)
by: Jan Smetana, et al.
Published: (2018-03-01)
Immunisation of young children against influenza — evidence review
by: V. A. Bulgakova, et al.
Published: (2022-10-01)
by: V. A. Bulgakova, et al.
Published: (2022-10-01)
Effect of Vaccination against Pneumococcal Infection and Influenza on the Clinical Course of Bronchial Asthma
by: N. P. Andreeva, et al.
Published: (2019-09-01)
by: N. P. Andreeva, et al.
Published: (2019-09-01)
Lessons learned from 2 years of influenza vaccinations in the UK and USA during the COVID-19 pandemic as respiratory viruses return
by: Litjen J. Tan, et al.
Published: (2022-11-01)
by: Litjen J. Tan, et al.
Published: (2022-11-01)
Detection of Twitter Users\' Attitudes about Flu Vaccine based on the Content and Sentiment Analysis of the Sent Tweets
by: Zahra Ghanbari, et al.
Published: (2019-03-01)
by: Zahra Ghanbari, et al.
Published: (2019-03-01)
Quadrivalent inactivated influenza vaccine (VaxigripTetra™)
by: Viviane Gresset-Bourgeois, et al.
Published: (2018-01-01)
by: Viviane Gresset-Bourgeois, et al.
Published: (2018-01-01)
Cost-effectiveness of the adjuvanted quadrivalent influenza vaccine for older adults in South Korea
by: Youngji Song, et al.
Published: (2024-12-01)
by: Youngji Song, et al.
Published: (2024-12-01)
Similar Items
-
Results of Clinical Trials of the First Russian 4-valent Flu Vaccine
by: D. A. Lioznov
Published: (2018-09-01) -
Knowledge, attitudes, beliefs, and barriers associated with the uptake of influenza vaccine among pregnant women
by: Ahmed Y. Mayet, et al.
Published: (2017-01-01) -
Reply letter to “Vaccine effectiveness of recombinant and standard dose influenza vaccines against outpatient illness during 2018–2019 and 2019–2020 calculated using a retrospective test-negative design”
by: Sanjay Hadigal, et al.
Published: (2023-08-01) -
Reply letter to “Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized Phase III trial”
by: Sanjay Hadigal, et al.
Published: (2022-11-01) -
Trends in influenza vaccine disparities in the U.S. following the introduction of COVID-19: Insights from the national health interview survey
by: Margaret L. Lind, et al.
Published: (2025-12-01)
